financetom
Business
financetom
/
Business
/
Northrop Grumman Revenue Outlook Robust, International Growth Seen as Multi-Year Tailwind, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Northrop Grumman Revenue Outlook Robust, International Growth Seen as Multi-Year Tailwind, RBC Says
Aug 20, 2025 8:14 AM

10:50 AM EDT, 08/20/2025 (MT Newswires) -- Northrop Grumman's ( NOC ) revenue outlook is robust, and the company could produce double-digit international growth for several years, RBC Capital Markets said.

The brokerage said in a Tuesday note that funding for Northrop's B-21 bomber is increasing, which indicates a faster development pace. It also said that negotiations on pricing for the B-21 "appear to be constructive."

Analysts said the company's international growth could represent a strong tailwind for multiple years as defense spending increases globally. They added that international revenue as a higher proportion of Northrop's total revenue could also boost the company's margins.

RBC said that considering Northrop's B-21 bomber, Sentinel program, growth in international revenues, and other opportunities that potentially include contracts for the Golden Dome defense system, "investors will reward NOC for upside to the growth expectations."

The brokerage retained an outperform rating and raised the stock's price target to $650 from $625.

Price: 589.28, Change: +3.05, Percent Change: +0.52

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved